A new analysis reveals that in patients discharged following left atrial appendage occlusion (LAAO), a direct oral anticoagulant (DOAC) antithrombotic strategy is linked to a significantly lower risk of major adverse events (MAE) when compared with anticoagulation plus aspirin.